Both in Pharmaceuticals
Gossamer Bio vs MAIA Biotechnology
Over the past year GOSS returned −94.4% and MAIA returned −23.4%; their daily moves had a correlation of -0.01.
GOSS −94.4% MAIA −23.4%Growth of $1, one year, split-adjusted
| Metric | GOSS | MAIA |
|---|---|---|
| Price | $11.85 | $1.18 |
| Market cap | $72.5M | $72.9M |
| Today | +2.33% | +2.61% |
| 1 month | −12.9% | −9.9% |
| 6 months | −54.9% | −15.7% |
| Year to date | −95.2% | −22.9% |
| 1 year | −94.7% | −26.3% |
| Revenue growth (YoY) | −19.6% | — |
| Gross margin | 100.0% | — |
| Net margin | 182.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.4× | — |
| Net cash | $20.9M | $27.6M |
| Dividend yield | — | — |
| Volatility (60d) | 1,269.5% | 49.2% |
| Short % of float | 16.4% | 4.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).